Press Release Title

Press release body 16 pt

Press Release Subheader 18 pt bold

 

Inhalon Biopharma is a rapidly growing startup with a patented breakthrough technology for preventing and treating acute respiratory infections such as respiratory syncytial virus (RSV), metapneumovirus (MPV) and SARS-CoV-2. The Company just completed a Seed round and has been awarded funding by the US Army to run a Phase 1/2a study in COVID-19 patients and has multiple NIH/SBIR grants to develop its pipeline of treatments for RSV, MPV, and influenza. Inhalon operates out of Durham, NC and the SF Bay Area.

Contact

 

To apply for a position, please send your resume and cover letter to hr@inhalon.com.